Market News / Story
FluoGuide enrols first patient in US brain cancer trial
MFN by Modular Finance ·
MFN by Modular Finance reports: FluoGuide has started enrolment in its US phase II trial of FG001 in high-grade glioma. It is the company’s first trial under its US IND, and a step on the road towards approval in the US. The news comes days after FluoGuide signed a collaboration agreement with microscope maker Leica Microsystems focused on the same indication. Read the full article at biostock.se: https://biostock.se/en/2026/10/fluoguide-enrols-first-patient-in-us-brain-cancer-trial/ This…